A phase 2 open-label extension study of prekallikrein inhibition with donidalorsen for hereditary angioedema. Petersen RS, Bordone L, Riedl MA, Tachdjian R, et al. Allergy 2024;79:724-734.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Petersen RS, Bordone L, Riedl MA, Tachdjian R, et al. A phase 2 open-label extension study of prekallikrein inhibition with donidalorsen for hereditary angioedema. Allergy 2024;79:724-734.
PMID: 38009241